Title: Optimisation of molecular testing in newly-diagnosed acute myeloid leukaemia (AML) in Wales

Funder
Novartis Pharmaceuticals UK Ltd

Principal Investigator

Project Details
Net value award figure for Cardiff University: £260,000.00
Start date: 01/06/2019
End date: 31/05/2021

Last updated on 2020-06-08 at 06:01